✦ LIBER ✦

Increased blood requirements during long-term transfusion therapy for sickle cell disease

✍ Scribed by Alan R. Cohen; George R. Buchanan; Marie Martin; Kwaku Ohene-Frempong

Book ID: 117163404
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 272 KB
Volume: 118
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(05)82155-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Less intensive long-term transfusion the

Less intensive long-term transfusion therapy for sickle cell anemia and cerebrovascular accident

✍ Scott T. Miller; Diane Jensen; Sreedhar P. Rao 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 370 KB

Manual erythroexchange for chronic trans

Manual erythroexchange for chronic transfusion therapy in patients with sickle cell syndromes unresponsive to hydroxyurea: A long-term follow-up

✍ Paola Carrara; Manuela Balocco; Valeria Pinto; Francesca Olcese; Anna Soldà; Pao 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

## Nothing to report. a Costs estimates for a 55-Kg patient based on: STT 5 2: filtered, washed, without buffy coat red blood cell units (250 ml Ht 80%)/ 4 week ? 249/ RBC U € 3 2 5 498 €. Desferoxamine f. 2g ? 11.05 € (40 mg/kg 3 5 days/week 5 11 g/week ? 5 f/ week 3 52 weeks/year). MEEX 5 2: fil

Risk of recurrent stroke in children wit

Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke

✍ Douglas J. Scothorn; Cynthia Price; Daniel Schwartz; Cindy Terrill; George R. Bu 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 103 KB

History of blood transfusion before 1990

History of blood transfusion before 1990 is associated with increased risk for cancer mortality independently of liver disease: a prospective long-term follow-up study

✍ Yusuke Inoue; Yasuhiko Wada; Yutaka Motohashi; Akio Koizumi 📂 Article 📅 2009 🏛 Japan Science and Technology Information Aggregato 🌐 English ⚖ 167 KB

High-dose therapy with peripheral blood

High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors

✍ K. Neben; S. Hohaus; H. Goldschmidt; G. Egerer; M. T. Voso; A. D. Ho; R. Haas 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 118 KB

Hematologic improvement in a patient wit

Hematologic improvement in a patient with gaucher disease on long-term enzyme replacement therapy: Evidence for decreased splenic sequestration and improved red blood cell survival

✍ Dr. Robert I. Parker; Elizabeth J. Read; Norman W. Barton; Roscoe O. Brady 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 860 KB